SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
29 Novembre 2023 - 1:00PM
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage
biopharmaceutical company focused on severe rare diseases and
cancer, today announced that management will participate in a
fireside chat at the 6th Annual Evercore ISI HealthCONx Conference,
taking place in Miami, Florida on Thursday, November 30, 2023 at
8:45 a.m. ET.
To access the live webcast please visit the Events &
Presentations page within the Investors & Media section of the
company’s website at https://ir.springworkstx.com. A replay of the
webcast will be available on SpringWorks’ website for a limited
time following the conference.
About SpringWorks Therapeutics
SpringWorks is a commercial-stage biopharmaceutical company
applying a precision medicine approach to developing and delivering
life-changing medicines for people with severe rare diseases and
cancer.
Founded in 2017, SpringWorks has a diversified targeted oncology
pipeline spanning solid tumors and hematological cancers, including
clinical trials in rare tumor types and highly prevalent,
genetically defined cancers. OGSIVEO™, approved in the United
States for the treatment of adult patients with progressing desmoid
tumors who require systemic treatment, is SpringWorks’ first
FDA-approved therapy. SpringWorks’ strategic approach and
operational excellence in clinical development have enabled it to
rapidly advance its lead product candidates into late-stage trials
and enter into multiple collaborations with innovators in industry
and academia to unlock the full potential for its portfolio and
create more solutions for patients with cancer.
For more information, visit www.springworkstx.com and
follow @SpringWorksTx on X (formerly Twitter), LinkedIn,
and YouTube.
Contacts:Kim DiamondVice President,
Communications and Investor RelationsPhone: 203-561-1646 Email:
kdiamond@springworkstx.com
Samantha Hilson SandlerSenior Director, Investor RelationsPhone:
203-461-5501Email: samantha.sandler@springworkstx.com
Grafico Azioni SpringWorks Therapeutics (NASDAQ:SWTX)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni SpringWorks Therapeutics (NASDAQ:SWTX)
Storico
Da Set 2023 a Set 2024